FinancialSports Medicine

Global Sports Medicine Market 2020-2025: Developments in the Field of Regenerative Medicine & Rising Demand for Minimally Invasive Surgeries

DUBLIN, Oct. 28, 2020 /PRNewswire/ — The “Global Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers & Clinics) and Region – Analysis & Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The global sports medicine market is projected to reach USD 7.2 billion by 2025 from USD 5.5 billion in 2020, growing at a CAGR of 5.7%.

This report studies the sports medicine market based on product, application, region and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders.

Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

“The Body Support & Recovery Products segment is expected to grow at the highest rate during the forecast period.”

On the basis of product, the global sports medicine market has been segmented into body reconstruction products, body support & recovery products, and accessories. The body reconstruction products segment is further divided into fracture and ligament repair products, arthroscopy devices, implants, prosthetics, and orthobiologics.

Similarly, body support & recovery products include braces & support, physiotherapy equipment, and compression clothing. The body reconstruction products segment is expected to grow at the highest CAGR during the forecast period. Braces & supports are required before and after procedures involving reconstruction. The demand for these devices is growing due to their requirement in the treatment of the majority of the sports injuries.

“The knee injuries segment is expected to hold the largest share during the forecast period.”

On the basis of application, the sports medicine market is segmented into knee injuries, shoulder injuries, foot & ankle injuries, elbow & wrist injuries, back & spine injuries, hip & groin injuries, and other injuries. The knee injuries segment is expected to account for the largest share of this market. The large share of this segment can be attributed to knee injuries being the most common sports injury accounting for approximately 40% of all injuries.

“The Hospitals segment is expected to account for the largest share during the forecast period.”

Based on end user segment, the market is segmented into Hospitals, Ambulatory Surgery centers and Physiotherapy Centers and Clinics. The hospitals segment accounted for the largest share of the sports medicine market. The large share of this segment can be attributed to factors like Complex diagnostic and therapeutic procedures being carried out in hospitals.

“The North American sports medicine market is expected to hold the largest market during the forecast period.”

Geographically, the sports medicine market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The North American market is expected to hold the largest share while Asia Pacific is to account for the highest CAGR of 6.1% during the forecast period. The rising popularity of sports and physical activity, growing awareness regarding the prevention & treatment of sports injuries, and increasing investments in sports medicine are the key factors driving the North American sports medicine market.

Impact of COVID-19 Pandemic on the Sports Medicine Market

The sports medicine market is a growing healthcare field owing to the rise in popularity of several sports activities and relevant opportunities. However, the erstwhile growing market has come to a standstill as most of the sporting events and activities have been put on hold because of the COVID-19 outbreak. Hospitals which are the largest growing end user segment have seen an incline in the treatment of COVID-19 cases which in turn has led to cancellation or rescheduling of sports related orthopedic injuries. The growth of the sports medicine market is hampered because of the novel coronavirus but is expected to be restored once the situation stabilizes.

Market Dynamics

Drivers

  • Increasing Incidence of Sports Injuries
  • The Continuous Influx of New Products and Treatment Modalities
  • Developments in the Field of Regenerative Medicine
  • Rising Demand for Minimally Invasive Surgeries

Restraints

  • High Cost of Orthopedic Implants and Other Devices

Opportunities

  • 3D-Printed Implants
  • Expansion and Market Penetration Opportunities in Emerging Economies

Challenges

  • Dearth of Skilled Professionals
  • Impact of the COVID-19 Pandemic on the Sports Medicine Market

Company Profiles

  • Arthrex, Inc.
  • Bauerfeind AG
  • Biotek
  • Breg, Inc.
  • Conmed Corporation
  • Cramer Products
  • Depuy Synthes Companies (Part of Johnson & Johnson)
  • DJO Global, Inc. (Subsidiary of Colfax Corporation)
  • Karl Storz GmbH & Co. KG
  • Medshape
  • Medtronic plc
  • Mueller Sports Medicine, Inc.
  • Performance Health International Limited
  • RG Sports Medicine
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Biomet Holdings, Inc.
  • Ossur

For more information about this report visit https://www.researchandmarkets.com/r/h43hiq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Print Friendly, PDF & Email
Tags

Chris J. Stewart

Chris currently serves as Chief Executive Officer of Surgio Health as well as COO at Ortho Spine Partners. Chris has close to 20 years of healthcare management experience with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that solve real problems that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help drive better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button
Close